RSV F vaccine: Phase I started

Novavax began a single-blind, placebo-controlled, Canadian Phase I trial to evaluate intramuscular RSV F vaccine with or without aluminum phosphate adjuvant in 150 healthy volunteers aged 2-6 years. ...